<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.inveslogic.com">
<channel>
 <title>Blog Articles Tagged with &#039;biotech&#039; at http://www.inveslogic.com</title>
 <link>http://www.inveslogic.com/tags/biotech</link>
 <description>Blog Articles Tagged with &#039;biotech&#039; at http://www.inveslogic.com</description>
 <language>en</language>
<item>
 <title>China Bio Week-in-Review: Trials and Deals</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1119824?rsstype=tag&amp;tag=biotech</link>
 <description>The news in China biotech last week revolved around two major topics: trial results/approvals and deals. On the test results front, Bridge Laboratories made a long-awaited announcement: the FDA accepted its China-developed data for review (see story)...</description>
 <pubDate>Sun, 07 Sep 2008 08:59:55 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1119824?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Five Presentations from the Recent Biotech Investment Conference</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1119129?rsstype=tag&amp;tag=biotech</link>
 <description>Medivation&#039;s Presentation: Standing Room Only A little more than 24 hours after announcing its big, lucrative Alzheimer&#039;s drug partnership with Pfizer (PFE), Medivation (MDVN)had the lead-off position (I wonder if they told organizers they&#039;d be a new...</description>
 <pubDate>Fri, 05 Sep 2008 04:12:14 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1119129?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Five Presentations from the Recent Biotech Investment Conference</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1119264?rsstype=tag&amp;tag=biotech</link>
 <description>Medivation&#039;s Presentation: Standing Room Only A little more than 24 hours after announcing its big, lucrative Alzheimer&#039;s drug partnership with Pfizer (PFE), Medivation (MDVN)had the lead-off position (I wonder if they told organizers they&#039;d be a new...</description>
 <pubDate>Fri, 05 Sep 2008 04:12:14 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1119264?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Biotech Outlook: M&amp;A Will Continue</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1117543?rsstype=tag&amp;tag=biotech</link>
 <description>Checking on the biotechnology sector, we spoke with Zacks senior analyst Grant Zeng, CFA about recent developments among these companies. We discussed M&amp;A [mergers and acquisitions] activity as well as top Buy recommendations. How has earnings season...</description>
 <pubDate>Tue, 02 Sep 2008 03:31:52 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1117543?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Biotech Outlook: M&amp;A Will Continue</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1117619?rsstype=tag&amp;tag=biotech</link>
 <description>Checking on the biotechnology sector, we spoke with Zacks senior analyst Grant Zeng, CFA about recent developments among these companies. We discussed M&amp;A [mergers and acquisitions] activity as well as top Buy recommendations. How has earnings season...</description>
 <pubDate>Tue, 02 Sep 2008 03:31:52 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1117619?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Investing in Biotech: The 3 Phases of Clinical Trials</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1117389?rsstype=tag&amp;tag=biotech</link>
 <description>Investing in biotech can be incredibly exciting and rewarding. After all, there&#039;s nothing like getting in early on a company with a novel drug for cancer, diabetes or any other debilitating disease - watching the drug successfully navigate clinical t...</description>
 <pubDate>Mon, 01 Sep 2008 06:57:02 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1117389?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Investing in Biotech: The 3 Phases of Clinical Trials</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1117499?rsstype=tag&amp;tag=biotech</link>
 <description>Investing in biotech can be incredibly exciting and rewarding. After all, there&#039;s nothing like getting in early on a company with a novel drug for cancer, diabetes or any other debilitating disease - watching the drug successfully navigate clinical t...</description>
 <pubDate>Mon, 01 Sep 2008 06:57:02 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1117499?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>China Biotech Week in Review: First Overseas FDA Office</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1117319?rsstype=tag&amp;tag=biotech</link>
 <description>Last week   s news from the China biomedical world started off with a flurry of announcements that were unusual in their uniformity: each centered on the subject of Deals and Financings. As the week progressed, the news developed a greater diversity ...</description>
 <pubDate>Mon, 01 Sep 2008 03:27:44 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1117319?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Jasmine Flower-Derived Substance, Potential New Anti-Cancer?</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-weblog/1115293?rsstype=tag&amp;tag=biotech</link>
 <description>Photo courtesy of iStockphoto, Grigory Bibikov Research findings lead by Prof. Eliezer Flescher of The Sackler Faculty of Medicine, Tel Aviv University reported that a compound derived from the jasmine flower could be the key to a new effective thera...</description>
 <pubDate>Tue, 26 Aug 2008 06:50:33 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-weblog/1115293?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Micromet: Another Seal of Approval</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1114666?rsstype=tag&amp;tag=biotech</link>
 <description>There is always a debate regarding market efficiency and to what extent stock prices represent the available information about a company. Micromet   s (MITI) surge last week shows that in some cases, the market is far from being efficient. The spike ...</description>
 <pubDate>Thu, 21 Aug 2008 02:33:29 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1114666?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Biotech ETFs: Can You Handle 209% Volatility?</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113993?rsstype=tag&amp;tag=biotech</link>
 <description>Years ago, I thought that I could divine the future of the biotech companies. Account damaging stock gaps from failed    sure thing    phase   three studies and unexpected drug side-effects required a reassessment of how to successfully invest in the...</description>
 <pubDate>Tue, 19 Aug 2008 03:56:38 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113993?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>China Biotech Week in Review: Earnings, Earnings, Earnings</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113454?rsstype=tag&amp;tag=biotech</link>
 <description>Last week was a big week for earning announcements from China life science enterprises: a total of eight companies announced their results. Earnings reports far overshadowed almost any other kind of news from the China life sciences sector. For the m...</description>
 <pubDate>Sun, 17 Aug 2008 10:34:40 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113454?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>5 Potential Buyout Targets in Biotech - Barron&#039;s</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113456?rsstype=tag&amp;tag=biotech</link>
 <description>Bristol-Myers Squibb (BMY) made a $4.5B bid for the shares of ImClone (IMCL) it doesn&#039;t already own. Roche Holdings (RHHBY.PK) made a $44B offer for the shares of Genetech (DNA) it doesn&#039;t own. Both targets want the bid prices raised. Barron&#039;s Lawren...</description>
 <pubDate>Sun, 17 Aug 2008 06:50:10 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113456?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Updates on the Healthcare/Biotech Mergers</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113462?rsstype=tag&amp;tag=biotech</link>
 <description>Before I get to my favorite biotech saga, there are noteworthy, if not newsworthy, press releases out this morning from two takeout targets. Genentech (DNA) put out a statement from the special independent board committee that&#039;s been appointed to han...</description>
 <pubDate>Thu, 14 Aug 2008 03:08:43 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113462?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>My Model Biotech Picks: What&#039;s Hot and What&#039;s Not</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113468?rsstype=tag&amp;tag=biotech</link>
 <description>Analyzing the performance of my previous picks is by far my favorite part of writing this blog. It has on many occasions allowed be to learn from my mistakes.I have moved the numbers to Google docs so that they are easier to read. Click   here to enl...</description>
 <pubDate>Wed, 13 Aug 2008 03:36:18 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1113468?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Just What the Doctor Ordered: Healthcare and Biotech ETF Review</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1112221?rsstype=tag&amp;tag=biotech</link>
 <description>There haven   t been many places for equity investors to hide over the past few months. Since hitting their highs in October of last year, the Dow Jones Industrial Average, the S&amp;P 500 and the Nasdaq Composite Index have all entered bear market terri...</description>
 <pubDate>Mon, 11 Aug 2008 07:08:34 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1112221?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>China Biotech Week in Review: Earnings and More</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1112222?rsstype=tag&amp;tag=biotech</link>
 <description>Last week, China biopharma saw news across a broad front. Earnings season is definitely underway, with three companies reporting, and there were developments in other areas     deals, drugs     as well.   A significant venture capital funding was for...</description>
 <pubDate>Mon, 11 Aug 2008 06:45:17 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1112222?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Will Myriad Genetics Keep Its Momentum?</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1112233?rsstype=tag&amp;tag=biotech</link>
 <description>I have found that one of the hardest things to do in the financial markets is to trade drug/biotech companies. I always like to play the markets based upon my perception of the underlying market psychology, but the problem with the drug/biotech compa...</description>
 <pubDate>Fri, 08 Aug 2008 05:48:01 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1112233?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Beyond the Business Plan: Managing unexpected risk in biotechnology business development</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-blog/1112214?rsstype=tag&amp;tag=biotech</link>
 <description>Here   s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to illustrate the elements which are important to consider after penning your business plan, and to help position oneself to be prepared ...</description>
 <pubDate>Wed, 06 Aug 2008 10:16:13 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-blog/1112214?rsstype=tag&amp;tag=biotech</guid>
</item>
<item>
 <title>Wall Street Breakfast: Must-Know News</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1111589?rsstype=tag&amp;tag=biotech</link>
 <description>  Freddie CEO ignored red flags. Freddie Mac (FRE) CEO Richard Syron chose to ignore internal warnings that, if heeded, could have shielded the GSE from some of its current devastation. As early as 2004, then chief risk officer David Andrukonis told ...</description>
 <pubDate>Tue, 05 Aug 2008 06:41:12 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1111589?rsstype=tag&amp;tag=biotech</guid>
</item>
</channel>
</rss>
